Doktorgradsavhandling

• Tarek Mazzawi; Magdy El-Salhy (2015). The Role of Diet in Irritable Bowel Syndrome with special reference to Gut Neuroendocrine System. (ekstern lenke)

Fagbok

• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2012). Irritable Bowel Syndrome: Diagnosis, Pathogenesis and Treatment Options. (ekstern lenke)

Forelesning

• Tarek Mazzawi; Gülen Arslan Lied; Magdy El-Salhy et al. (2016). Kinetics of microbial community composition in patients with diarrhea-predominant irritable bowel syndrome following faecal microbiota transplantation. (ekstern lenke)

Konferanseabstrakt

• Magdy El-Salhy; Christina Casén; Jørgen Valeur et al. (2021). Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jørgen Valeur; Trygve Hausken et al. (2020). Changes in fecal short-chain fatty acids (SCFA) following fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome (IBS). (ekstern lenke)
• Magdy El-Salhy; Anja Bråthen Kristoffersen; Jørgen Valeur et al. (2020). Long-term effects of faecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Gülen Arslan Lied; Johannes Espolin Roksund Hov et al. (2018). Effects of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy; Gülen Arslan Lied et al. (2017). Effect of faecal microbiota transplantation on Neurogenin 3, Musahsi 1 and enteroendocrine cells in the duodenum of patients with irritable bowel syndrome. (ekstern lenke)
• Trygve Hausken; Tarek Mazzawi; Gülen Arslan Lied et al. (2017). Effect of faecal microbiota transplantation on the symptoms and gut microbiota in patients with irritable bowel syndrome (IBS). (ekstern lenke)
• Tarek Mazzawi; Jørgen Valeur; Trygve Hausken et al. (2017). Effect of faecal microbiota transplantation on gut bacterial fermentation products in patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Gülen Arslan Lied; Magdy El-Salhy et al. (2016). Kinetics of microbial community composition in patients with diarrhea-predominant irritable bowel syndrome following faecal microbiota transplantation. (ekstern lenke)
• Tarek Mazzawi; Gülen Arslan Lied; Magdy El-Salhy et al. (2016). Effect of fecal microbiota transplantation on the symptoms and duodenal enteroendocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Hilde K Østgaard et al. (2011). Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; J. Rauma (2009). Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with diabetes type 1. (ekstern lenke)

Konferanseforedrag

• Dag André Sangnes; Trond Engjom; Kristian Løvaas et al. (2023). Epidemiologi og patofysiologi ved diabetisk diaré (DIAREPA). (ekstern lenke)
• Magdy El-Salhy; Anja Bråthen Kristoffersen; Jørgen Valeur et al. (2020). Long-term effects of faecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Trygve Hausken; Johannes Espolin Roksund Hov et al. (2019). Effect of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome. (ekstern lenke)

Konferanseposter

• Magdy El-Salhy; Christina Casén; Jørgen Valeur et al. (2021). Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Gülen Arslan Lied; Johannes Espolin Roksund Hov et al. (2018). Effects of faecal microbiota transplantation on gut microenvironment and symptoms in patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy; Gülen Arslan Lied et al. (2017). Effect of faecal microbiota transplantation on Neurogenin 3, Musahsi 1 and enteroendocrine cells in the duodenum of patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Jørgen Valeur; Trygve Hausken et al. (2017). Effect of faecal microbiota transplantation on gut bacterial fermentation products in patients with irritable bowel syndrome. (ekstern lenke)

Lederartikkel

• Magdy El-Salhy (2019). Nutritional management of gastrointestinal diseases and disorders. (ekstern lenke)
• Magdy El-Salhy (2016). Diet in the pathophysiology and management of irritable bowel syndrome. (ekstern lenke)

Leserbrev

• Magdhy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk (2023). Letter: A step forward towards a standard FMT protocol for IBS. (ekstern lenke)
• Magdy El-Salhy (2021). FMT in IBS: How cautious should we be?. (ekstern lenke)
• Magdy El-Salhy; Trygve Hausken; Jan Gunnar Hatlebakk (2020). Letter: faecal microbiota transplantation for irritable bowel syndrome—which improvements are required?. (ekstern lenke)

Medieintervju

• Ingrid Spilde; Magdy El-Salhy; Tore Midtvedt et al. (2016). Irritabel tarm – fra psykisk til fysisk. (ekstern lenke)

Vitenskapelig artikkel

• Magdhy El-Salhy; Tora Skarvatun; Dag Arne Lihaug Hoff et al. (2026). Possible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome. (ekstern lenke)
• Magdhy El-Salhy; Jørgen Valeur; Ingeborg Brønstad et al. (2025). Possible Role of Butyric Acid in Long-Term Symptom Relief in Irritable Bowel Syndrome Patients Following Fecal Microbiota Transplantation. (ekstern lenke)
• Magdhy El-Salhy; Mads Johansson; Miriam Klevstul et al. (2025). Quality of life, functional impairment and healthcare experiences of patients with irritable bowel syndrome in Norway: an online survey. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk (2024). Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. (ekstern lenke)
• Magdhy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk (2024). Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome. (ekstern lenke)
• Magdhy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk (2023). Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females. (ekstern lenke)
• Magdhy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk (2023). Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Trygve Hausken; Magdy El-Salhy (2022). Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation. (ekstern lenke)
• Magdy El-Salhy; Renate Winkel; Christina Casén et al. (2022). Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at 3 years after transplantation. (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Trygve Hausken et al. (2022). The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms. (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Trygve Hausken et al. (2022). Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. (ekstern lenke)
• Magdy El-Salhy; Christina Casén; Jørgen Valeur et al. (2021). Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy; Gülen Arslan Lied et al. (2021). The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. (ekstern lenke)
• Magdy El-Salhy; Anja Bråthen Kristoffersen; Jørgen Valeur et al. (2021). Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jørgen Valeur; Trygve Hausken et al. (2020). Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Trygve Hausken; Jan Gunnar Hatlebakk (2020). Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja et al. (2019). Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. (ekstern lenke)
• Tarek Mazzawi; Trygve Hausken; Johannes Espolin Roksund Hov et al. (2019). Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken (2019). Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja et al. (2019). Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk (2019). Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting. (ekstern lenke)
• Magdy El-Salhy; Trygve Hausken; Jan Gunnar Hatlebakk (2019). Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). (ekstern lenke)
• Tarek Mazzawi; Gülen Arslan Lied; Dag André Sangnes et al. (2018). The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja (2017). Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy (2017). Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Trygve Hausken et al. (2017). Interaction between diet and gastrointestinal endocrine cells. (ekstern lenke)
• Magdy El-Salhy; Kazuo Umezawa; Jan Gunnar Hatlebakk et al. (2017). Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis. (ekstern lenke)
• Magdy El-Salhy; Tanisa Patcharatrakul; Jan Gunnar Hatlebakk et al. (2017). Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Tanisa Patcharatrakul; Jan Gunnar Hatlebakk et al. (2017). Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Kazuo Umezawa et al. (2016). Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja (2016). Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy (2016). Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. (ekstern lenke)
• Magdy El-Salhy; Kazuo Umezawa (2016). Effects of AP-1 and NF-κB inhibitors on colonic endocrine cells in rats with TNBS-induced colitis. (ekstern lenke)
• Magdy El-Salhy; Kazuo Umezawa (2016). Anti-inflammatory effects of novel AP-1 and NF-B inhibitors in dextran-sulfate-sodium-induced colitis in rats. (ekstern lenke)
• Magdy El-Salhy; Kazuo Umezawa (2016). Treatment with novel AP-1 and NF-B inhibitors restores the colonic endocrine cells to normal levels in rats with DSS-induced colitis. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy (2016). Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Trygve Hausken (2016). The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD). (ekstern lenke)
• Tarek Mazzawi; Trygve Hausken; Doris Irene Gundersen et al. (2016). Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk (2016). Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats. (ekstern lenke)
• Magdy El-Salhy (2015). Recent developments in the pathophysiology of irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jan G Hatlebakk; Odd Helge Gilja et al. (2015). Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen (2015). Diet in irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Trygve Hausken; Doris Irene Gundersen et al. (2015). Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jan G Hatlebakk; Trygve Hausken (2015). Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. (ekstern lenke)
• Tarek Mazzawi; Doris Irene Gundersen; Trygve Hausken et al. (2015). Increased chromogranin A cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2014). Abnormal rectal endocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Kazuo Umezawa; Odd Helge Gilja et al. (2014). Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Doris Irene Gundersen et al. (2014). Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Jan G Hatlebakk et al. (2014). Stomach antral endocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Doris Irene Gundersen et al. (2014). Endocrine cells in the ileum of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Trygve Hausken (2014). Chromogranin A cells in the stomachs of patients With sporadic irritable bowel syndrome. (ekstern lenke)
• Tarek Mazzawi; Doris Irene Gundersen; Trygve Hausken et al. (2014). Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Doris Irene Gundersen et al. (2014). Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome. (ekstern lenke)
• Ingvild Haukaas Wendelbo; Tarek Mazzawi; Magdy El-Salhy (2013). Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease. (ekstern lenke)
• Magdy El-Salhy; Ingvild Haukaas Wendelbo; Doris Irene Gundersen et al. (2013). Colonoscopy with mucosal biopsies in young rats: A model for experimental gastroenterology. (ekstern lenke)
• Tarek Mazzawi; Trygve Hausken; Doris Irene Gundersen et al. (2013). Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2013). Low‑grade inflammation in the rectum of patients with sporadic irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Ingvild Haukaas Wendelbo; Doris Irene Gundersen (2013). Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Ingvild Haukaas Wendelbo; Doris Irene Gundersen (2013). Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Doris Irene Gundersen et al. (2013). Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. (ekstern lenke)
• Magdy El-Salhy; Ingvild Haukaas Wendelbo; Doris Irene Gundersen et al. (2013). Evaluation of the usefulness of colonoscopy with mucosal biopsies in the follow-up of TNBS-induced colitis in rats. (ekstern lenke)
• Magdy El-Salhy; Hege Østgaard; Doris Irene Gundersen et al. (2012). The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2012). High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Doris Irene Gundersen et al. (2012). Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2012). Chromogranin A cell density as a diagnostic marker for lymphocytic colitis. (ekstern lenke)
• Hege Østgaard; Trygve Hausken; Doris Irene Gundersen et al. (2012). Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Inge Seim; Lisa Chopin et al. (2012). Irritable bowel syndrome: the role of gut neuroendocrine peptides. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Hege Østgaard et al. (2012). Low Densities of Serotonin and Peptide YY Cells in the Colon of Patients with Irritable Bowel Syndrome. (ekstern lenke)
• Magdy El-Salhy (2012). Irritable bowel syndrome: Diagnosis and pathogenesis. (ekstern lenke)
• Magdy El-Salhy; Jörg Michael Halwe; Bjarne Lomholt-Beck et al. (2011). The prevalence of inflammatory bowel diseases, microscopic colitis, and colorectal cancer in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Bjarne Lomholt-Beck; Doris Irene Gundersen (2011). The prevalence of celiac disease in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Bjarne Lomholt-Beck; TD Gundersen (2011). High chromogranin A cell density in the colon of patients with lymphocytic colitis. (ekstern lenke)
• Vernesa Dizdar; Robin Spiller; Gulzar Singh et al. (2010). Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. (ekstern lenke)
• Magdy El-Salhy; Elli Lillebø; Astrid Reinemo et al. (2010). Effects of a health program comprising reassurance, diet management, probiotics administration and regular exercise on symptoms and quality of life in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Bjarne Lomholt-Beck; Trygve Hausken (2010). Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Kirsi Kaarina Vaali; Vernesa Dizdar et al. (2010). Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jussi Rauma (2009). Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes. (ekstern lenke)
• Magdy El-Salhy; Eli Lillebø; Astrid Reinemo et al. (2009). Ghrelin in patients with irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy (2009). Ghrelin in gastrointestinal diseases and disorders: A possible role in the pathophysiology and clinical implications (Review). (ekstern lenke)

Vitenskapelig bokkapittel

• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2013). Diet and Irritable Bowel Syndrome, with a Focus on Appetite-Regulating Gut Hormones. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Magdhy El-Salhy; Maura Corsetti; Odd Helge Gilja et al. (2026). Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome. (ekstern lenke)
• Magdhy El-Salhy (2023). Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue. (ekstern lenke)
• Magdy El-Salhy; Trygve Hausken; Jan Gunnar Hatlebakk (2021). Current status of fecal microbiota transplantation for irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit (2021). The role of diet in the pathophysiology and management of irritable bowel syndrome. (ekstern lenke)
• Jun Ma; Yuyang Zhang; Takeshi Sugai et al. (2021). Inhibition of cellular and animal inflammatory disease models by nf-κb inhibitor dhmeq. (ekstern lenke)
• Magdy El-Salhy (2020). Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken (2019). Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi (2018). Fecal microbiota transplantation for managing irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Synne Otteraaen Ystad; Tarek Mazzawi et al. (2017). Dietary fiber in irritable bowel syndrome (Review). (ekstern lenke)
• Magdy El-Salhy; Solomon Tefera; Trygve Hausken et al. (2017). Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel Disease. (ekstern lenke)
• Tarek Mazzawi; Magdy El-Salhy (2017). Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). (ekstern lenke)
• Magdy El-Salhy; Trygve Hausken; Odd Helge Gilja et al. (2016). The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja et al. (2015). The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy (2015). Recent advances in the diagnosis of irritable bowel syndrome. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Odd Helge Gilja et al. (2014). Is irritable bowel syndrome an organic disorder?. (ekstern lenke)
• Magdy El-Salhy; Rune Svensen; Jan G Hatlebakk et al. (2014). Chronic constipation and treatment options (Review). (ekstern lenke)
• Magdy El-Salhy; Odd Helge Gilja; Doris Irene Gundersen et al. (2014). Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review). (ekstern lenke)
• Magdy El-Salhy; Jan G Hatlebakk; Odd Helge Gilja et al. (2014). Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2013). Clinical presentation, diagnosis, pathogenesis and treatment options for lymphocytic colitis (Review). (ekstern lenke)
• Magdy El-Salhy; Tarek Mazzawi; Doris Irene Gundersen et al. (2013). The role of peptide YY in gastrointestinal diseases and disorders (Review). (ekstern lenke)
• Inge Seim; Magdy El-Salhy; Trygve Hausken et al. (2012). Ghrelin and the brain-gut axis as a pharmacological target for appetite control. (ekstern lenke)
• Magdy El-Salhy; Doris Irene Gundersen; Jan G Hatlebakk et al. (2012). Irritable bowel syndrome: treatment options. (ekstern lenke)

Vitenskapelig monografi

• Magdy El-Salhy; Jan G Hatlebakk; Trygve Hausken (2015). Understanding and Controlling the Irritable Bowel. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.